Jo Appleyard - Ryman Healthcare Independent Non-Executive Director

RYHTY Stock  USD 13.65  0.16  1.19%   

Director

Ms. Jo Appleyard is NonExecutive Independent Director of Ryman Healthcare Ltd. Jo is a partner at Chapman Tripp. She is a skilled advocate and litigator specialising in commercial, employment, and resource management law. Jo was a member of the NZ Markets Disciplinary Tribunal since 2011. since 2009.
Tenure 15 years
Phone64 3 366 4069
Webhttps://www.rymanhealthcare.co.nz

Ryman Healthcare Management Efficiency

Ryman Healthcare's management efficiency ratios could be used to measure how well Ryman Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 2.58 B in total debt with debt to equity ratio (D/E) of 0.76, which is about average as compared to similar companies. Ryman Healthcare has a current ratio of 0.7, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Ryman Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, Ryman Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ryman Healthcare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ryman to invest in growth at high rates of return. When we think about Ryman Healthcare's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Donald WilsonBarloworld Ltd ADR
59
Peter EckertSCOR PK
70
Babalwa NgonyamaBarloworld Ltd ADR
40
Peter SchmidBarloworld Ltd ADR
53
Kory SorensonSCOR PK
49
Michele AronvaldSCOR PK
57
Bruno PfisterSCOR PK
59
John DePodestaGen Digital
74
Wang ZhenSCOR PK
61
Sibongile MkhabelaBarloworld Ltd ADR
60
JeanMarc RabySCOR PK
59
Maria SingerUniversal Health Services
46
Jane WickerMiurinSCOR PK
59
Joshua HausmanGen Digital
N/A
Warren NimetzUniversal Health Services
64
Kevin KnoerSCOR PK
58
Hester HickeyBarloworld Ltd ADR
62
Augustin RomanetSCOR PK
55
Ngozichukwuka EdozienBarloworld Ltd ADR
48
Neo DongwanaBarloworld Ltd ADR
44
David ReisGen Digital
56
Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. The company was founded in 1984 and is based in Christchurch, New Zealand. Ryman Healthcare operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 6700 people. Ryman Healthcare [RYHTY] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Ryman Healthcare Leadership Team

Elected by the shareholders, the Ryman Healthcare's board of directors comprises two types of representatives: Ryman Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ryman. The board's role is to monitor Ryman Healthcare's management team and ensure that shareholders' interests are well served. Ryman Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ryman Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
Claire Higgins, Non-Executive Independent Director
Anthony Leighs, Independent Director
Cameron Holland, Chief Australia
Richard Umbers, Group Exec
Gordon MacLeod, CFO, Deputy Chief Executive and Company Secretary
Kevin Hickman, Co-Founder, Director and Member of Remuneration and Nominations Committee
Taylor Allison, Design Manager
Michelle Perkins, IR Contact Officer
Simon Challies, CEO, Managing Director, Executive Director
Tom Brownrigg, Construction Manager
Jo Appleyard, Independent Non-Executive Director
Jenn Poskitt, Marketing Manager
Philip Mealings, Property and Purchasing Manager
George Savvides, Independent Director
Douglas McKay, Independent Director
Cheyne Chalmers, Chief Zealand
Debbie McClure, Group Sales Manager
Warren Bell, Independent Non-Executive Director
David Bennett, Group Officer
Deborah Marris, G Sec
Marsha Cadman, Chief Officer
Rick Davies, Chief Officer
Andrew Mitchell, Development Manager
David Kerr, Independent Non-Executive Chairman of the Board
Geoffrey Cumming, Director
MaryAnne Stone, Chief Officer
David King, Corporate Affairs Manager
Chris BE, Chief Officer
Barbara ReynenRose, Operations & Clinical Services Manager
Nicole Forster, Group Shared Services Manager

Ryman Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Ryman Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ryman Healthcare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ryman Healthcare's short interest history, or implied volatility extrapolated from Ryman Healthcare options trading.

Currently Active Assets on Macroaxis

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ryman Healthcare. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Complementary Tools for Ryman Pink Sheet analysis

When running Ryman Healthcare's price analysis, check to measure Ryman Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ryman Healthcare is operating at the current time. Most of Ryman Healthcare's value examination focuses on studying past and present price action to predict the probability of Ryman Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ryman Healthcare's price. Additionally, you may evaluate how the addition of Ryman Healthcare to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Please note, there is a significant difference between Ryman Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ryman Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ryman Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.